Kaken Pharmaceutical Company Ltd (PK) (KKPCF)
USOTC
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End March 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 101.48B | 98.43B | 94.17B | 89.23B | 74.98B | 76.03B | 72.98B | 72.04B |
| Operating Income | 30.71B | 27.5B | 24.59B | 26.22B | 17.79B | 14.07B | 6.11B | 9.47B |
| Pre Tax Income | 31.09B | 27.69B | 24.92B | 26.59B | 18.66B | 13.89B | 6.82B | 9.8B |
| Net Income | 22.02B | 19.04B | 17.78B | 19.37B | 13.41B | 9.55B | 5.44B | 8.03B |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 454.521 | 393.126 | 366.949 | 421.637 | 291.794 | 207.858 | 118.372 | 174.706 |
| EBIT | 30.55B | 27.32B | 24.52B | 26.11B | 18.09B | 13.39B | 6.4B | 9.39B |
| EBITDA | 32.64B | 29.62B | 26.74B | 28.82B | 20.11B | 19.55B | 10.54B | 12.25B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
